ArticleOncotarget2017

Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism.

Yi-Yong Baek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.